Wouter L J Hinrichs (Wouter Lj Hinrichs)

DAI Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Topics

Molecularly Imprinted

Hyaluronic Acid

Platelet Rich Plasma

Ulcerative Colitis

Top Venues

Expert review of vaccines

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Primawan Putra Nugrahadi, Wouter L J Hinrichs, Henderik W Frijlink, Christian Schöneich, Christina Avanti
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics 15 (3) (2023)
Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Primawan Putra Nugrahadi, Wouter L J Hinrichs, Henderik W Frijlink, Christian Schöneich, Christina Avanti
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics 15 (3) (2023)
Primawan Putra Nugrahadi, Wouter L J Hinrichs, Henderik W Frijlink, Christian Schöneich, Christina Avanti
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics 15 (3) (2023)
Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Rick Heida, Paul Hagedoorn, Melle C van Meel, Jurrie E R Prins, Frederike S Simonis, Renate Akkerman, Anke L W Huckriede, Henderik W Frijlink, Anne H de Boer, Wouter L J Hinrichs
Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice. Pharmaceutics 15 (7) (2023)
Khanh T T Nguyen, Daan Zillen, Franca F M Heijningen, Kjeld J C van Bommel, Renz J van Ee, Henderik W Frijlink, Wouter L J Hinrichs
Surface Engineering Methods for Powder Bed Printed Tablets to Optimize External Smoothness and Facilitate the Application of Different Coatings. Pharmaceutics 15 (9) (2023)
Rick Heida, Philip A Born, Gabriela Tapia-Calle, Henderik W Frijlink, Anna Salvati, Anke L W Huckriede, Wouter L J Hinrichs
Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Evalyne M Jansen, Henderik W Frijlink, Wouter L J Hinrichs, Mitchel Jr Ruigrok
Are inhaled mRNA vaccines safe and effective? A review of preclinical studies. Expert opinion on drug delivery 19 (11) (2022)
Khanh T T Nguyen, Franca F M Heijningen, Daan Zillen, Kjeld J C van Bommel, Renz J van Ee, Henderik W Frijlink, Wouter L J Hinrichs
Formulation of a 3D Printed Biopharmaceutical: The Development of an Alkaline Phosphatase Containing Tablet with Ileo-Colonic Release Profile to Treat Ulcerative Colitis. Pharmaceutics 14 (10) (2022)
Rick Heida, Wouter L J Hinrichs, Henderik W Frijlink
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19. Expert review of vaccines (2021)
Renée S van der Kooij, Rob Steendam, Johan Zuidema, Henderik W Frijlink, Wouter L J Hinrichs
Microfluidic Production of Polymeric Core-Shell Microspheres for the Delayed Pulsatile Release of Bovine Serum Albumin as a Model Antigen. Pharmaceutics 13 (11) (2021)
Annemarie Broesder, Julia M E Berends, Sophie M Scheepers, Duong N Nguyen, Henderik W Frijlink, Wouter L J Hinrichs
Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems. Pharmaceutics 13 (5) (2021)
Annemarie Broesder, Said Y Bircan, Anneko B de Waard, Anko C Eissens, Henderik W Frijlink, Wouter L J Hinrichs
Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery. Pharmaceutics 13 (12) (2021)
Yu Tian, Yoshita C Bhide, Herman J Woerdenbag, Anke L W Huckriede, Henderik W Frijlink, Wouter L J Hinrichs, J Carolina Visser
Development of an Orodispersible Film Containing Stabilized Influenza Vaccine. Pharmaceutics 12 (3) (2020)
Katie Amssoms, Philip A Born, Max Beugeling, Ben De Clerck, Ellen Van Gulck, Wouter L J Hinrichs, Henderik W Frijlink, Niels Grasmeijer, Guenter Kraus, Roger Sutmuller, Kenny Simmen, Lieven Baert
Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice. PloS one 13 (8) (2018)